FDA MedWatch - Praxair Inc., Grab ‘n Go Vantage Portable Oxygen Cylinder Units: Class I Recall - Risk of Fire Inside Cylinder Unit

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

 



Title: FDA MedWatch - Praxair Inc., Grab ‘n Go Vantage Portable Oxygen Cylinder Units: Class I Recall - Risk of Fire Inside Cylinder Unit
MedWatch logoMedWatch - The FDA Safety Information and Adverse Event Reporting Program

Praxair Inc., Grab ‘n Go Vantage Portable Oxygen Cylinder Units: Class I Recall - Risk of Fire Inside Cylinder Unit

AUDIENCE: Risk Manager

ISSUE: Praxair Inc. issued a recall of the Grab 'n Go Vantage Portable Oxygen Cylinder unit because fires may occur inside the cylinder unit causing the wall of the unit to break and release oxygen. The fires are self extinguishing and may be caused by physical impact such as dropping or knocking over the cylinder unit. If a fire occurs, users may experience burns or a lack of oxygen (hypoxia). This product may cause serious adverse health consequences, including death.

BACKGROUND: The Grab 'n Go Vantage Portable Oxygen Cylinder unit consists of an oxygen container and pressure regulator (valve). The pressure regulator (valve) is intended for medical purposes and is used to convert a medical gas pressure from a high variable pressure to a lower, more constant working pressure.

RECOMMENDATION: On November 26, 2012, Praxair, Inc. sent "Medical Device Correction" letters to customers and distributors describing the product, problem, and actions to be taken. Customers were also instructed to send Grab’n Go Vantage Portable Oxygen Cylinder units to Praxair, Inc. for servicing and refilling after use in accordance with their normal processes.


Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

Read the medWatch safety alert, including a link to the recall notice, at:

http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm333881.htm


This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery

[Index of Archives]     [CDC News]     [NIH News]     [USDA News]     [Steve's Art]     [Camping in Yosemite]     [PhotoForum]     [SB Lupus]     [STB]

  Powered by Linux